Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (TMO)
NYSE:TMO
TMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$493.30 - $627.88
Previous CloseN/A
Volume471.20K
Average Volume (3M)1.89M
Market Cap
$195.32B
Enterprise Value$226.53B
Total Cash (Recent Filing)$5.51B
Total Debt (Recent Filing)$35.61B
Price to Earnings (P/E)31.3
Beta0.72
Next Earnings
Apr 23, 2025EPS Estimate
5.11Last Dividend Ex-Date
Mar 14, 2025Dividend Yield0.3%
Share Statistics
EPS (TTM)16.52
Shares Outstanding377,261,170
10 Day Avg. Volume1,696,764
30 Day Avg. Volume1,892,158
Financial Highlights & Ratios
PEG Ratio4.56
Price to Book (P/B)N/A
Price to Sales (P/S)4.56
Price to Cash Flow (P/CF)14.80
P/FCF Ratio14.80
Enterprise Value/Market Cap1.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit12.51
Enterprise Value/Ebitda19.79
Forecast
1Y Price Target
$662.00Price Target Upside27.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTMO delivered a strong performance in 4Q24, with revenue up by 4.7% YoY and adjusted EPS up by 7.6%, beating consensus.
Market PositionThe acquisition would enhance Thermo Fisher's existing offerings and strengthen its position in the bioprocessing market.
Strategic AcquisitionThe acquisition of SOLV's Purification and Filtration business is expected to bolster Thermo Fisher Scientific's position in bioprocessing.
Bears Say
Earnings ImpactThe acquisition is expected to be dilutive to earnings per share in the first year, indicating a potential short-term financial drawback.
Market VolatilitySolventum has experienced volatility in its bioprocessing segment, which may pose a challenge for Thermo Fisher.
Operating MarginThe acquired business is dilutive on operating margin and accounts for only a small percentage of Thermo Fisher Scientific's sales, suggesting limited impact from dilution.
---
Ownership Overview
0.12% Insiders
24.56% Mutual Funds
27.50% Other Institutional Investors
29.63% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TMO FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was $493.30 and its highest was $627.88 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $195.32B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Apr 23, 2025 which is in 30 days.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Jan 30, 2025. The company reported $6.1 earnings per share for the quarter, beating the consensus estimate of $5.942 by $0.158.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.3%. See more information on Thermo Fisher dividends here
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 5.11.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 377,261,170 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of $6.1 in its last earnings report, beating expectations of $5.942. Following the earnings report the stock price went up 6.778%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in TMO
---
Thermo Fisher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$662.00 (27.87% Upside)
$662.00 (27.87% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 83%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 335.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.11%
12-Months-Change
Fundamentals
Return on Equity
13.15%
Trailing 12-Months
Asset Growth
-1.42%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science, offering a comprehensive range of products and services to various industries, including healthcare, pharmaceuticals, biotechnology, and academia. The company operates in four primary segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Thermo Fisher's core products and services include laboratory equipment, reagents, consumables, software, and services that enable scientific research, drug discovery, diagnostics, and manufacturing.
---
TMO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong finish to 2024 with significant revenue and earnings growth, positive customer feedback, and successful innovation and capital deployment. However, there are some challenges with declines in pharma and biotech, and diagnostics and healthcare segments for the full year, as well as potential policy uncertainties.Read More>---
TMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
---
TMO Stock 12 Month Forecast
Average Price Target
$662.00
▲(27.87% Upside)
Technical Analysis
Best Analysts Covering TMO
1 Year
1 Year Success Rate
26/41 ratings generated profit
1 Year Average Return
+13.77%
reiterated a buy rating 2 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 63.41% of your transactions generating a profit, with an average return of +13.77% per trade.
---